SLXP | Quote | Chart | News | PowerRating -- (Comment on this article at http://www.financialwire.net/2009/11/19/salix-pharmaceuticals-prices-common-share-offering/)
November 19, 2009 (FinancialWire) -- Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP | Quote | Chart | News | PowerRating) has priced a public offering of 5.5 million shares of its common stock. The offering is scheduled to close on or about November 23.
The company has granted the underwriter a 30-day option to purchase up to an additional 825,000 shares to cover over-allotments, if any.
Salix plans to use the net proceeds from the offering for business development activities and other general corporate purposes.
Raleigh, North Carolina-based Salix Pharmaceuticals develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases.
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Free annual reports, filings and conference call webcasts for companies mentioned in the news are available via Investrend Syndications (http://investrend.ar.wilink.com/?level=279).
http://www.financialwire.net
For full details on Salix Pharmaceuticals Ltd (SLXP) SLXP. Salix Pharmaceuticals Ltd (SLXP) has Short Term PowerRatings at TradingMarkets. Details on Salix Pharmaceuticals Ltd (SLXP) Short Term PowerRatings is available at This Link.
- Salix Pharmaceuticals Releases 4th Quarter and 2009 Financial Results - 03/15/10
- Salix Pharmaceuticals Posts 4Q and FY 2009 Results - 03/11/10
- Salix Pharmaceuticals Ltd (SLXP) Corporate Event Announcement Notice - 03/10/10
- Salix expects big drop in sales - 03/10/10
- BiomedReports: News and FDA Updates for Salix (NASDAQ:SLXP), Teva (NASDAQ:TEVA), Urigen (OTC:URGP) - 03/10/10
- More News >>


